Regular medication as a risk factor for intracranial aneurysms: A comparative case-control study.

Ramazan Jabbarli Marvin Darkwah OppongMehdi ChihiThiemo Florin DingerMaryam SaidJan RodemerkPhilipp DammannBörge SchmidtCornelius DeuschlNika GuberinaKarsten H WredeUlrich Sure

Published in: European stroke journal (2022)

Regular medication might impact the risks related to the development and rupture of IA. Further clinical trials are required to clarify the effect of regular medication on IA genesis.

Keyphrases

clinical trial
healthcare
adverse drug
risk assessment
human health
study protocol